(Q34727307)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

main subject

cerebrovascular disease

1 reference

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

J Rosell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

B Nordenskjöld

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

N-O Bengtsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

T Fornander

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

T Hatschek

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

H Lindman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

P-O Malmström

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

A Wallgren

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

O Stål

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

language of work or name

English

0 references

publication date

22 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

899-902

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer

23 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065281

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065281

Hormone therapy and cardiovascular disease: a systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065281

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065281

Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065281

Meta-analysis of vascular and neoplastic events associated with tamoxifen

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065281

Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065281

Reliability of the hospital registry. The diagnostic data are better than their reputation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065281

Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065281

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2011.45

What do we know about duloxetine's mode of action? Evidence from animals to humans

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2011.45

Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: results from a randomized trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2011.45

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21343938

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21343938

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2011.45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

23 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21343938%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

PubMed publication ID

21343938

1 reference